COX 2 inhibitor rejected in North America but retained in Europe

COX-2 inhibitor.

he developed severe psoriasis responsive only to repeated courses of the then newly available PUVA (psoralen plus UVA radiation) therapy. Between 1973 and 1993 he received PUVA once a week. During treatment no genital protection was used although he had never received UV therapy directly to the genital area. Two years after the onset of psoriasis he developed peripheral inflammatory arthritis. ...

Government and Environmental Innovation in Europe and North America

This article challenges certain tenets of the theories of reflexive law and ecological modernization. While far-sighted prevention-oriented and structural changes are needed, some proponents of these theories argue that the very industries and firms that create environmental problems can, through continuous institutional learning; the application of life cycle analysis; dialogue and networks wi...

Lyme arthritis in Europe: comparisons with reports from North America.

Fgd Technology Developments in Europe and North America

Over the past twenty years there have been significant advances in the design and operation of Flue Gas Desulfurization (FGD) systems. Due to the differences in fuels and economic pressures, advances have been different in North America and Europe. This paper will discuss the evolution of the FGD technology focusing on the limestone/gypsum process. Babcock Borsig Power (BBP) has approximately 4...

Coltiviruses and Seadornaviruses in North America, Europe, and Asia

Coltiviruses are tickborne viruses of the genus Coltivirus. The type species, Colorado tick fever virus (from North America), has been isolated from patients with flulike syndromes, meningitis, encephalitis, and other severe complications. Another coltivirus, Eyach virus, has been isolated from ticks in France and Germany and incriminated in febrile illnesses and neurologic syndromes. Seadornav...